Thesla Palanee
Biographic Data
| ID | 1732956 |
|---|---|
| NAME | Thesla Palanee |
| GIVEN NAMES | Thesla |
| FAMILY NAME | Palanee |
| SIGNATURE | PALANEE T |
| AFFILIATIONS | Perinatal HIV Research Unit |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 1 |
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa
Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel
Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel
Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
Medicine (3 works) · Microbicide (3 works) · Adolescent Sexual and Reproductive Health (2 works) · Environmental health (2 works) · Family medicine (2 works) · HIV/AIDS Research and Interventions (2 works) · Human immunodeficiency virus (HIV (2 works) · Microbicides for sexually transmitted diseases (2 works) · Placebo (2 works) · Population (2 works)